1Y Close · As of Aug 26, 2026
Genesystem operates in the Medical, Precision & Optical sector.
Legal name: Genesystem Co., Ltd
In fiscal year 2025, Genesystem (363250) reported revenue of 381 million KRW, down 68.4% from 1.2 billion KRW a year earlier.
Operating profit was -9.7 billion KRW and net income was -14.7 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 34.4 billion KRW, with a P/B of 4.44.
These figures can be verified in the DART filing (receipt no. 20260324000016).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 381M | -9.7B | -14.7B |
| 2024 | 1.2B | -10.1B | -9.5B |
| 2023 | 897M | -9.5B | -8.1B |
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-27 | Guarantee Decision |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-07 | 유형자산취득결정(종속회사의주요경영사항) |
| 2026-07-30 | 주요사항보고서(타법인주식및출자증권양수결정) |